A prospective randomized trial comparing anastrozole and clomiphene citrate in an ovulation induction protocol using gonadotropins.

Author: DavisWilliam A, MaifeldMichelle, SipeChristopher S, Van VoorhisBradley J

Paper Details 
Original Abstract of the Article :
OBJECTIVE: To compare the ovarian and endometrial effects of anastrozole and clomiphene when used with gonadotropins in a combination protocol. DESIGN: Prospective randomized trial. SETTING: Academic infertility center. PATIENT(S): Fifty infertile women. INTERVENTIONS(S): Women were randomized t...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.fertnstert.2006.05.048

データ提供:米国国立医学図書館(NLM)

Anastrozole vs. Clomiphene Citrate: A Race to the Finish Line

The [treatment of infertility] is a journey filled with both hope and uncertainty, like a caravan crossing a vast desert. This research, like a race against time, compares the effects of two medications, anastrozole and clomiphene citrate, when used with gonadotropins in a [prospective randomized trial] for ovulation induction. The authors sought to determine which medication, like a racing camel, would lead to the most favorable outcomes for patients seeking to conceive.

Anastrozole: A Potential Game Changer?

The results, like a well-placed checkpoint, revealed that anastrozole, while leading to fewer follicles and lower E(2) levels, was associated with similar pregnancy rates compared to clomiphene citrate. This suggests that anastrozole, like a swift camel, may offer a safer and more effective alternative for certain patients, particularly those at higher risk of hyperstimulation or multiple births.

Finding the Right Path: A Personalized Approach

This research, like a guidepost in the desert, highlights the importance of individualized treatment. Both anastrozole and clomiphene citrate have their own unique characteristics, and finding the right medication for each patient, like finding the right path through the desert, is essential. The quest for effective and safe treatments for infertility continues, fueled by research and a commitment to providing individualized care.

Dr. Camel's Conclusion

The findings of this study, like a beacon of hope in the desert, suggest that anastrozole may be a promising option for ovulation induction in certain patients. It's crucial to remember, however, that each patient is unique, and finding the right treatment pathway requires careful consideration of individual needs and potential risks. As we continue to explore the desert of infertility, we must remain committed to personalized medicine and evidence-based approaches.

Date :
  1. Date Completed 2006-12-19
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

17007849

DOI: Digital Object Identifier

10.1016/j.fertnstert.2006.05.048

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.